1 Review of Ongoing Activities and Challenges to Improve the Care of Patients With Type 2 Diabetes Across Africa and the Implications for the Future.

2 Climate Change: Impact, Adaptation, and Vulnerability

3 development studies of captopril certified reference material

4 organizational, legal, medical and pharmaceutical approaches to optimization of medicines’ circulation for hypertonia treatment in countryside areas

5 prevalence and covariates of polypharmacy in elderly patients on discharge from a tertiary care hospital in oman

6 ao persistirem os sintomas, o médico deverá ser consultado: isto é regulação? if your symptoms fail to improve, consult a doctor: is this regulation?

7 reações adversas causadas por fármacos que atuam no sistema nervoso: análise de registros de um centro de farmacovigilância do brasil adverse reaction caused by drugs acting in nervous system: records analysis of a farmacovigilance center in brazil

8 determination of carbamazepine in pharmaceutical formulations

9 analysis of antimicrobials' consumption profile in a university hospital of western paraná, brazil

10 Determination of the biologically active flavour substances thujone and camphor in foods and medicines containing sage (Salvia officinalisL.)

11 Vitellaria paradoxa nutshells from seven sub-Saharan countries as potential herbal medicines for treating diabetes based on chemical compositions, HPLC fingerprints and bioactivity evaluation.

12 Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countries.

13 Bioactive glasses meet phytotherapeutics: The potential of natural herbal medicines to extend the functionality of bioactive glasses.

14 Medicines in the forest: Ethnobotany of wild medicinal plants in the pharmacopeia of the Wichí people of Salta province (Argentina)

15 Plants utilized as medicines by residents of Quilombo da Fazenda, Núcleo Picinguaba, Ubatuba, São Paulo, Brazil: A participatory survey.

16 Towards Printed Pediatric Medicines in Hospital Pharmacies: Comparison of 2D and 3D-Printed Orodispersible Warfarin Films with Conventional Oral Powders in Unit Dose Sachets.

17 Efficacy and safety of Chinese medicines for asthma: A systematic review protocol.

18 An experimental study of the anti-dysmenorrhea effect of Chinese herbal medicines used in Jin Gui Yao Lue.

19 Elimination of over-the-counter medicines from the health insurance coverage: A right or wrong decision

20 Benefits of global partnerships to facilitate access to medicines in developing countries: a multi-country analysis of patients and patient outcomes in GIPAP

21 The right to health as the basis for universal health coverage: A cross-national analysis of national medicines policies of 71 countries.

22 Exploring global and country-level barriers to an effective supply of leishmaniasis medicines and diagnostics in eastern Africa: a qualitative study.

23 A Cross-Sectional Investigation for Verification of Globalization of Falsified Medicines in Cambodia, Indicated by Tablets of Sildenafil Citrate.

24 Exploring medicines management by COPD patients and their social networks after hospital discharge.

25 [The role of German official medicines control laboratories in combating counterfeit medicines].

26 [Falsified medicines in parallel trade].

27 Networking hospital eprescribing: A systemic view of digitalization of medicines' use in England

28 Excellence in Family Paediatricians: the FIMP-MCRN (Medicines for Children Research Network) becomes a member of ENPR-EMA (European Network of Paediatric Research at the European Medicines Agency)

29 The FIMP Medicines for Children Research Network

30 Stakeholder perspectives on the challenges surrounding management and supply of essential medicines.

31 Worldwide Occurrence and Investigations of Contamination of Herbal Medicines by Tropane Alkaloids

32 Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency.

33 Toxicological screening and DNA sequencing detects contamination and adulteration in regulated herbal medicines and supplements for diet, weight loss and cardiovascular health.

34 The UNESCO Bioethics Declaration 'social responsibility' principle and cost-effectiveness price evaluations for essential medicines.

35 Therapeutic use of the rebound effect of modern drugs: "New homeopathic medicines".

36 A systematic review examining the effectiveness of medicines information services for patients and the general public.

37 [Counterfeit medicines: a growing threat].

38 Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis.

39 The impact of an integrated pharmacology and medicines management curriculum for undergraduate adult nursing students on the acquisition of applied drug/pharmacology knowledge.

40 Micro-morphological, environmental and phytochemical investigation of herbal medicines by using LM and SEM: A quality control tool

41 Impact of removal and restriction of me-too medicines in a hospital drug formulary on in- and outpatient drug prescriptions: interrupted time series design with comparison group

42 Commercialization of User Data by Developers of Medicines-Related Apps: a Content Analysis.

43 Reasons why insured consumers co-pay for medicines at retail pharmacies in Pretoria, South Africa.

44 Time-resolved fluorescent immunochromatographic assay-based on three antibody labels for the simultaneous detection of aflatoxin B and zearalenone in Chinese herbal medicines.

45 Factors associated with the use of complementary and alternative medicines for prostate cancer by long-term survivors.

46 Nanomedicines for developing cancer nanotherapeutics: from benchtop to bedside and beyond.

47 PEGylation: a promising strategy to overcome challenges to cancer-targeted nanomedicines: a review of challenges to clinical transition and promising resolution.

48 Modified Magnetic Nanoparticle-Based Solid-Phase Extraction for the Determination of Trace Amounts of Aflatoxins B and B₂ in Chinese Patent Medicines: The Use of Fupuganmao Granules as a Case Study.

49 Traditional Herbal Medicines for Diabetes Used in Europe and Asia: Remedies From Croatia and Sri Lanka.

50 Ethnoveterinary medicines used for ruminants in British Columbia, Canada

51 An Overview of the Orphan Medicines Market in Turkey.

52 The International Society for Pharmacoepidemiology's Comments on the Core Recommendations in the Summary of the Heads of Medicines Agencies (HMA) - EMA Joint Big Data Task Force.

53 Use of evidence and negotiation in the review of national standard treatment guidelines and essential medicines list: experience from Ghana.

54 [Parenteral administration medicines: recommendations of preparation, administration and stability].

55 Parenteral administration medicines: recommendations of preparation, administration and stability

56 Effects of safety warnings on prescription rates of cough and cold medicines in children below 2 years of age.

57 Evaluating the impact of the single exit price policy on a basket of originator medicines in South Africa from 1999 to 2014 using a time series analysis.

58 Emerging Role of Chinese Herbal Medicines in the Treatment of Pancreatic Fibrosis.

59 Should the poor have no medicines to cure? A study on the association between social class and social security among the rural migrant workers in urban China

60 Prescribing and Research in Medicines Management (UK & Ireland) Annual Conference 2018, NCVO, Society Building, London, UK, 14th December 2018: 'Person-centred Care in the Digital Age: Nudge, Nudge, Tweet, Tweet'

61 Traditional medicines and their in-vitro proof against Staphylococcus aureus in Pakistan

62 Prescription of Valproate-Containing Medicines in Women of Childbearing Potential who have Psychiatric Disorders: Is It Worth the Risk?

63 Affordable and equitable access to subsidised outpatient medicines? Analysis of co-payments under the Additional Drug Package in Kyrgyzstan.

64 Use of health outcome and health service utilization indicators as an outcome of access to medicines in Brazil: perspectives from a literature review.

65 THE CHALLENGES OF LEGAL REGULATION OF PUBLIC PROCUREMENT OF MEDICINES AND MEDICAL PRODUCTS IN UKRAINE.

66 Herbal medicines for diabetes control among Indian and Pakistani migrants with diabetes.

67 Building partnerships for linking biomedical science with traditional knowledge of customary medicines: a case study with two Australian Indigenous communities.

68 How government insurance coverage changed the utilization and affordability of expensive targeted anti-cancer medicines in China: an interrupted time-series study.

69 Is India ready to lead the battle for fair access to medicines?

70 Studying the impoverishing effects of procuring medicines: a national study.

71 Investigating the exposure of Iranian households to catastrophic health expenditure due to the need to purchase medicines.

72 A survey of availability, price and affordability of essential medicines from 2011 to 2016 in Chinese secondary and tertiary hospitals.

73 Unlocking Access To Novel Medicines In China-A Review From A Health System Perspective.

74 Herbal medicines and phytochemicals for obsessive-compulsive disorder.

75 Physicochemical Quality Assessment of Antimalarial Medicines: Chloroquine Phosphate and Quinine Sulfate Tablets from Drug Retail Outlets of South-West Ethiopia.

76 The universal physiological template—a system to advance medicines

77 Effects of dietary Chinese herbal medicines mixture on feeding attraction activity, growth performance, nonspecific immunity and digestive enzyme activity of Japanese seabass (Lateolabrax japonicus)

78 A review of existing and emerging digital technologies to combat the global trade in fake medicines.

79 A review of therapeutic agents and Chinese herbal medicines against SARS-COV-2 (COVID-19).

80 An early assessment of the efficacy of medicines in the treatment of patients with COVID-19

81 Review on the potential action mechanisms of Chinese medicines in treating Coronavirus Disease 2019 (COVID-19).

82 Selling my sheep to pay for medicines - household priorities and coping strategies in a setting without universal health coverage

83 Selling my sheep to pay for medicines – household priorities and coping strategies in a setting without universal health coverage

84 ‘She Used to Doctor Us up Herself’: Patent Medicines, Mothers, and Expertise in Early Twentieth-Century Britain

85 Traceability and detection of counterfeit medicines in pharmaceutical supply chain using blockchain-based architectures

86 Western herbal medicines in the treatment of irritable bowel syndrome: A systematic review and meta-analysis.

87 traditional chinese herbal medicines for treating hiv infections and aids

88 book review: "study of homoeopathic medicines through clinical verification" volume iii

89 consumo de medicamentos entre adultos na área de abrangência de uma unidade de saúde da família consumption of medicines by adults within an area covered by a family health unit

90 application of spontaneous photon emission in the growth ages and varieties screening of fresh chinese herbal medicines

91 farmácia: a porta de entrada para o acesso a medicamentos para idosos residentes em santos pharmacy: a gateway to access to medicines for elderly individuals living in the city of santos

92 protection of test data and exclusivity in medicines and agrochemicals: the interpretation of article 39.3 trips

93 medicines and its relation to the development of pressure injury in hospitalized-elderly people / medicamentos e sua relação com o desenvolvimento de lesão por pressão em idosos hospitalizados

94 treatment of diabetic gastroparesis by complementary and alternative medicines

95 access to medicines by ambulatory health service users in mexico: an analysis of the national health surveys 1994 to 2006 acceso a medicamentos para los usuarios del primer nivel de los servicios de salud: análisis de las encuestas nacionales de salud 1994, 2000 y 2006

96 when cure becomes an illness - abuse of addictive prescription medicines

97 prescriptions of chinese herbal medicines for insomnia in taiwan during 2002

98 pattern and appropriateness of medicines prescribed to outpatients at a university hospital in northwestern ethiopia

99 the potential of zebrafish as a model organism for improving the translation of genetic anticancer nanomedicines

100 uso racional de medicamentos: o papel fundamental do farmacêutico rational use of medicines: the pivotal role of the pharmacist

101 correcting india’s chronic shortage of drug inspectors to ensure the production and distribution of safe, high-quality medicines

Keyword Connections

Journals

Research Groups

Bibliographies